IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,997,375 | +60.0% | 186,706 | +34.0% | 1.18% | +57.3% |
| Q3 2022 | $2,499,000 | +165.9% | 139,315 | +42.5% | 0.75% | +185.6% |
| Q2 2022 | $940,000 | -23.7% | 97,745 | +33.5% | 0.26% | -4.4% |
| Q1 2022 | $1,232,000 | +0.7% | 73,196 | 0.0% | 0.28% | +10.4% |
| Q4 2021 | $1,224,000 | -31.6% | 73,196 | -33.6% | 0.25% | -4.6% |
| Q3 2021 | $1,790,000 | +9.7% | 110,231 | -57.4% | 0.26% | +11.1% |
| Q2 2021 | $1,632,000 | +119.9% | 258,580 | +115.3% | 0.24% | +109.8% |
| Q1 2021 | $742,000 | +19.7% | 120,075 | +33.9% | 0.11% | +3.7% |
| Q4 2020 | $620,000 | – | 89,665 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |